NASDAQ$PETS

PetMed Express · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Announced second quarter financial results, which included an increase in net sales and new customers, but a decrease in net income and adjusted EBITDA.

PetMed Express reported a 9% increase in net sales to $71.0 million, driven by the acquisition of PCRx. New customers increased by 25% year over year. However, net loss was $70 thousand, compared to a net income of $2.6 million in the prior year. Adjusted EBITDA decreased by 55% to $3.2 million due to increased expenses.

  • Net sales increased by 9% year over year to $71.0 million.
  • New customers increased by 25% year over year, marking the fourth consecutive quarter of growth.
  • Net loss was $70 thousand, compared to net income of $2.6 million in the prior year.
  • Adjusted EBITDA decreased by 55% to $3.2 million.

Headline financials

Total Revenue

$71M

Previous: $65.4M+8.6%
EPS (adj)

-$0.00

Previous: $0.13-102.6%
Capital Expenditures

-$2.14M

Previous: -$2.34M+8.5%
Free Cash Flow

-$2.35M

Previous: $2.77M-184.8%
Net Income

-$70K

Previous: $2.58M-102.7%
Operating Income

-$441K

Previous: $2.96M-114.9%
Gross Profit

$20.1M

Previous: $18.5M+8.7%
Cash & Equivalents

$53.5M

Previous: $96.5M-44.6%
Total Assets

$159M

Previous: $169M-5.9%
Stock-Based Comp

$1.73M

Previous: $1.68M+2.9%

Revenue & EPS history

PetMed Express · Revenue · Quarterly

$71M

Q2 2024+8.6%vs Q2 2023
Beat estimate in 3 of 14 quarters(21%)
ActualEstimate

Forward guidance

PetMed Express has decided to suspend the quarterly dividend to invest in organic and inorganic growth initiatives within the evolving pet care industry, aiming for higher shareholder returns.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

-0.0%

Avg return

Earnings day

-1.6%

Avg return

5 days after

-0.4%

Avg return

30 days after

42%

27 / 65 earnings

Positive

+40.8%

Q2 2020

Best reaction

-26.4%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-16.4%-21.1%
Q3 2026-3.6%-8.7%-15.5%
Q4 2025+0.0%-4.9%-6.6%
Q2 2026-1.4%-2.7%-8.2%
Q1 2026-1.1%-1.4%-6.9%
Q3 2025-14.8%-20.1%-22.7%
Q2 2025+34.5%+27.2%+35.0%
Q1 2025-11.0%-13.0%-4.5%
Q4 2024-0.7%-1.7%-7.4%
Q3 2024+0.2%-1.2%+8.9%
Q2 2024-26.4%-23.0%-22.6%
Q1 2024-2.8%-6.4%-20.0%
Q4 2023+6.7%+1.0%-6.6%
Q3 2023-11.1%-13.3%-19.6%
Q2 2023-10.5%-4.7%-15.5%
Q1 2023+4.3%+4.2%+0.9%
Q4 2022+6.9%+2.0%+3.0%
Q3 2022+7.2%+7.7%+3.4%
Q2 2022+5.1%+5.1%+5.2%
Q1 2022+7.1%+13.0%+3.2%
Q4 2021+2.8%+0.5%+56.5%
Q3 2021-14.3%-11.1%+3.2%
Q2 2021-2.2%-3.5%-1.9%
Q1 2021-16.0%-23.8%-17.4%
Q4 2020+3.6%-4.0%-7.5%
Q3 2020-11.0%-11.2%+4.0%
Q2 2020+40.8%+32.8%+21.7%
Q1 2020+2.5%-1.5%+5.1%
Q4 2019-9.0%-9.7%-18.9%
Q3 2019-6.2%-3.4%-3.1%
Q2 2019+2.6%+1.1%-9.7%
Q1 2019-13.0%-11.8%-6.4%
Q4 2018-0.9%+1.4%+15.1%
Q3 2018-4.8%-10.2%-12.0%
Q2 2018+4.4%-5.0%+9.0%
Q1 2018+18.6%+19.3%-10.7%
Q4 2017+34.7%+41.2%+48.4%
Q3 2017-5.1%-5.4%-3.6%
Q2 2017-3.2%-4.0%+6.6%
Q1 2017+6.0%+5.8%+3.3%
Q4 2016+2.9%
Q3 2016-4.8%
Q2 2016+2.1%
Q1 2016+0.5%
Q4 2015+2.6%
Q3 2015+14.3%
Q2 2015-3.7%
Q1 2015+5.0%
Q4 2014+1.6%
Q3 2014-12.0%
Q2 2014-10.3%
Q1 2014+12.7%
Q4 2013-0.5%
Q3 2013+7.0%
Q2 2013+6.9%
Q1 2013-16.3%
Q4 2012-5.4%
Q4 2010-5.4%
Q3 2011-0.2%
Q3 2012-0.2%
Q2 2012-0.8%
Q2 2011-0.8%
Q1 2012-0.1%
Q1 2011-0.1%
Q4 2011-0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro